We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$617M
(+40%)
Cap. Flow
+$399M
Cap. Flow
% of AUM
18.35%
Top 10 Holdings %
Top 10 Hldgs %
22.83%
Holding
3,224
New
565
Increased
1,310
Reduced
679
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$52.4M |
| 2 |
Panagram BBB-B CLO ETF
CLOZ
|
+$37.6M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.3M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$24.4M |
| 5 |
Merck
MRK
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.9M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$20.7M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$19.4M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.2M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 4.24% |
| 3 | Healthcare | 3.21% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Biogen
BIIB
$30.5B
| $41.8K | ﹤0.01% |
333
+118
| +55% | +$14.7K |
|
1327
Bunge Global
BG
$20.9B
| $41.6K | ﹤0.01% |
518
+149
| +40% | +$11.7K |
|
|
WBA
1328
DELISTED
Walgreens Boots Alliance
WBA
| $41.3K | ﹤0.01% |
3,558
-795
| -18% | -$8.85K |
|
|
CIVI
1329
DELISTED
Civitas Resources
CIVI
| $41.3K | ﹤0.01% |
1,499
+1,137
| +314% | +$32.9K |
|
1330
Cameco
CCJ
$40.8B
| $41.2K | ﹤0.01% |
556
-728
| -57% | -$38.8K |
|
1331
Diodes
DIOD
$4.55B
| $41.2K | ﹤0.01% |
779
+753
| +2,896% | +$33.1K |
|
1332
Baxter International
BAX
$14B
| $41.2K | ﹤0.01% |
1,314
-45
| -3% | -$1.36K |
|
1333
Fabrinet
FN
$19.5B
| $41K | ﹤0.01% |
139
-10
| -7% | -$2.23K |
|
1334
DaVita
DVA
$11.5B
| $40.9K | ﹤0.01% |
287
+48
| +20% | +$6.8K |
|
1335
iShares MSCI Intl Quality Factor ETF
IQLT
$14.1B
| $40.6K | ﹤0.01% |
+939
| New | +$39K |
|
1336
TKO Group
TKO
$13.7B
| $40.6K | ﹤0.01% |
223
+46
| +26% | +$7.39K |
|
1337
Invesco
IVZ
$14B
| $40.5K | ﹤0.01% |
2,570
-9,463
| -79% | -$136K |
|
1338
Assured Guaranty
AGO
$3.66B
| $40.5K | ﹤0.01% |
465
+192
| +70% | +$16.4K |
|
1339
Lazard
LAZ
$4.22B
| $40.5K | ﹤0.01% |
844
-16
| -2% | -$669 |
|
1340
Textron
TXT
$15.1B
| $40.1K | ﹤0.01% |
+500
| New | +$36.2K |
|
1341
Vodafone
VOD
$37B
| $40.1K | ﹤0.01% |
3,763
-1,574
| -29% | -$15.2K |
|
1342
ORIX
IX
$44.8B
| $40.1K | ﹤0.01% |
1,217
+1,072
| +739% | +$22K |
|
1343
Avantor
AVTR
$8.91B
| $39.9K | ﹤0.01% |
2,961
+754
| +34% | +$10.3K |
|
1344
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $39.7K | ﹤0.01% |
608
+597
| +5,427% | +$38K |
|
1345
Boston Beer
SAM
$1.88B
| $39.7K | ﹤0.01% |
134
+92
| +219% | +$21.2K |
|
1346
First Trust Energy AlphaDEX Fund
FXN
$369M
| $39.6K | ﹤0.01% |
2,610
+989
| +61% | +$14.6K |
|
1347
Loews
L
$23.7B
| $39.6K | ﹤0.01% |
243
+113
| +87% | +$9.92K |
|
1348
Commault Systems
CVLT
$5.53B
| $39.4K | ﹤0.01% |
+226
| New | +$38.6K |
|
1349
Deutsche Bank
DB
$70.7B
| $39.4K | ﹤0.01% |
1,344
+1,330
| +9,500% | +$35.1K |
|
1350
News Corp Class A
NWSA
$16B
| $39.3K | ﹤0.01% |
1,324
+136
| +11% | +$3.74K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Arax Advisory Partners held 3,224 positions worth $2.18B, up 40% from $1.56B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Arax Advisory Partners deployed $399M of net new capital in Q2 2025, opening 565 new positions and adding to 1,310 existing holdings. Its largest new stake was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $21.9M trimmed.
- Arax Advisory Partners's largest Q2 2025 buy was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
- Arax Advisory Partners added most to Axon Enterprise in Q2 2025, an estimated $52.4M increase.
- Arax Advisory Partners's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $21.9M.
- Arax Advisory Partners fully exited YieldMax MSTR Option Income Strategy ETF in Q2 2025, selling an estimated $102K.
- Arax Advisory Partners's ten largest holdings make up 23% of its $2.18B portfolio in Q2 2025.
- Arax Advisory Partners opened 565 new positions and closed 193 in Q2 2025.
- Arax Advisory Partners's portfolio value rose 40% quarter-over-quarter to $2.18B.
Based on Arax Advisory Partners's 13F filing for Q2 2025, filed 12 Aug 2025.